Просмотр по теме "Lysosomal storage diseases"

Отображаемые элементы 1-3 из 3

New approaches to Tay-Sachs disease therapy

Solovyeva V.; Shaimardanova A.; Chulpanova D.; Kitaeva K.; Chakrabarti L.; Rizvanov A. (2018)

Copyright © 2018 Solovyeva, Shaimardanova, Chulpanova, Kitaeva, Chakrabarti and Rizvanov. Tay-Sachs disease belongs to the group of autosomal-recessive lysosomal storage metabolic disorders. This disease is caused by ...
Serum cytokine profile, beta-hexosaminidase a enzymatic activity and gm<inf>2</inf> ganglioside levels in the plasma of a tay-sachs disease patient after cord blood cell transplantation and curcumin administration: A case report

Shaimardanova A.A.; Chulpanova D.S.; Solovyeva V.V.; Garanina E.E.; Salafutdinov I.I.; Laikov A.V.; Kursenko V.V.; Chakrabarti L.; Zakharova E.Y.; Bukina T.M.; Baydakova G.V.; Rizvanov A.A. (2021)

Tay-Sachs disease (TSD) is a progressive neurodegenerative disorder that occurs due to a deficiency of a β hexosaminidase A (HexA) enzyme, resulting in the accumulation of GM2 gangliosides. In this work, we analyzed the ...
Tay-Sachs disease: Diagnostic, modeling and treatment approaches

Solovyeva V.V.; Shaimardanova A.A.; Chulpanova D.S.; Kitaeva K.V.; Rizvanov A.A. (2020)

© 2020, Human Stem Cell Institute. All rights reserved. Tay-Sachs disease (OMIM 272800) belongs to the group of autosomal-recessive disorders, caused by β-hexosaminidase A (HexA) enzyme deficiency, resulting in GM2-ganglioside ...

Отображаемые элементы 1-3 из 3

Поиск в электронном архиве